Close Menu

DNAnexus

Seeking to tap into the burgeoning next-generation sequencing-based diagnostics market, DNANexus has begun offering cloud infrastructure for clinical testing laboratories to run their analysis pipelines and store data.

Station X has launched GenePool, a cloud-based software application to manage, analyze, and communicate genomic and clinical information. Users can analyze sequence information from both DNA and RNA to identify biomarkers.

Station X has launched GenePool, a cloud-based software application to manage, analyze, and communicate genomic and clinical information. Users can analyze sequence information from both DNA and RNA to identify biomarkers.

Eagle Genomics, a UK-based bioinformatics software and services provider, said this week that it plans to use a recent influx of funds to complete development on ElasticAp, a cloud-based analysis product that the company hopes to launch early next year.

DNAnexus has appointed Arthur Cole as general manager of Europe. He will be based in the UK and will be responsible for the company's marketing, sales, and business development activities across the European market.

People in the News: Arthur Cole

Premium

DNAnexus has hired Arthur Cole as general manager in charge of marketing, sales, and business development activities across the European market.

DNANexus said this week that it has hired Omar Serang to be its chief cloud officer.

DNAnexus has appointed Ken Kershner to vice president of engineering and Omar Serang to chief cloud officer, a newly created position.

DNANexus has hired Ken Kershner to serve as its vice president of engineering.

DNAnexus has launched a developer program that offers bioinformaticians and software engineers the technical and support resources needed to create and integrate data analysis applications on its platform.

Pages

A South African university has told the Wellcome Sanger Institute to return DNA samples it has from indigenous African communities, The Times reports.

The University of California, Berkeley's Rasmus Nielsen and Xinzhu Wei have retracted their CCR5 gene paper due to a technical artifact.

 

University of Virginia researchers are exploring a genetic risk test to gauge type 1 diabetes risk, NPR reports.

In PNAS this week: researchers compare two high-grade neuroendocrine lung cancers, height among ancient Europeans, and more.